InvestorsHub Logo
Followers 49
Posts 9775
Boards Moderated 1
Alias Born 01/31/2008

Re: Hoskuld post# 431293

Monday, 09/18/2023 2:51:02 PM

Monday, September 18, 2023 2:51:02 PM

Post# of 461418
How about actually submitting the NDAs?

The CEO is doing...really well. Over 10 years, he has brought the company from P1 to the brink of submitting NDAs for 2 indications. And pivotal trials for 2 additional indications (Fragile X and PD) are teed up. There is not much else, IMO, that you could ask for from a biotech CEO:



550 hp, 640 lb-ft, 0-60 in 3.8 seconds

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News